Skip to main content

Peer Review reports

From: Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial

Original Submission
19 May 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
27 Jun 2021 Reviewed Reviewer Report
1 Dec 2021 Reviewed Reviewer Report - Beatrice Borelli
11 Dec 2021 Author responded Author comments - Akira Ooki
Resubmission - Version 3
11 Dec 2021 Submitted Manuscript version 3
22 Dec 2021 Author responded Author comments - Akira Ooki
Resubmission - Version 4
22 Dec 2021 Submitted Manuscript version 4
5 Jan 2022 Reviewed Reviewer Report
12 Jan 2022 Reviewed Reviewer Report - Beatrice Borelli
18 Feb 2022 Author responded Author comments - Akira Ooki
Resubmission - Version 5
18 Feb 2022 Submitted Manuscript version 5
Publishing
11 May 2022 Editorially accepted
28 Jun 2022 Article published 10.1186/s12885-022-09811-x

You can find further information about peer review here.

Back to article page